Drug Profile
Research programme: bradykinin B1 receptor antagonists - Jerini
Latest Information Update: 24 Mar 2010
Price :
$50
*
At a glance
- Originator Jerini
- Class Small molecules
- Mechanism of Action Bradykinin B1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Pain
Most Recent Events
- 05 Dec 2007 Early research in Inflammation in Germany (PO)
- 05 Dec 2007 Early research in Pain in Germany (PO)